Press release
Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year
– Gilead Also Included on the Dow Jones Sustainability North America Index; Rankings Reflect Gilead’s Ongoing Commitment to Corporate Responsibility – – DJSI
About this update from Gilead Sciences, Inc.
[{"type":"text","content":"\n– Gilead Also Included on the Dow Jones Sustainability North America Index; Rankings Reflect Gilead’s Ongoing Commitment to Corporate Responsibility –\n\n\n– DJSI World Highlights the Most Sustainable Companies Around the World Based on Corporate Sustainability Assessment –\n\n\n FOSTER CITY, Calif.--(BUSINESS WIRE)--\nGilead Sciences, Inc. (Nasdaq: GILD) today announced the company has once again been recognized as one of the most sustainable pharmaceutical companies according to the Dow Jones Sustainability World Index (DJSI World) for the third consecutive year. The company was also included on the Dow Jones Sustainability North America Index (DJSI North America). These rankings are based on an in-depth analysis of Gilead’s sustainability performance and highlight the company’s longstanding sustainable business practices and transparency on environmental, social and governance (ESG) issues.\n\n\n“We are very pleased that Gilead’s commitment to corporate responsibility is recognized once again with inclusion on the Dow Jones Sustainability World Index,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences. “By investing in world-class science, driving access to our therapies and addressing societal barriers to care, Gilead’s work is helping to create a healthier world for all people.”\n\n\nGilead’s ESG strategy aims to position the company as an employer of choice that delivers shareholder value in a sustainable, responsible manner. Gilead’s focus on scientific innovation and sustainable business practices is centered around the needs of patients, employees and communities around the world. Examples of Gilead’s commitment to ESG include:\n\n\n\nExpanding health equity around the world through programs that promote health system sustainability, strengthen infrastructure and provide education and financial support\n\n\n\nIncreasing access to medicines in low- and lower-middle income countries, including voluntary licensing for Gilead’s HIV, hepatitis C and COVID-19 treatments\n\n\n\nCreating an inclusive workplace that is representative of the diverse communities the company serves\n\n\n\nContinuing to evolve the company’s environmental sustainability program and setting ambitious goals that further embed sustainability into the business across four focus areas of carbon, water, waste and product\n\n\n\nThe...